171 related articles for article (PubMed ID: 9296213)
1. Aromatase inhibitors come of age.
Dowsett M
Ann Oncol; 1997 Jul; 8(7):631-2. PubMed ID: 9296213
[No Abstract] [Full Text] [Related]
2. New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
de Jong PC; Blijham GH
Neth J Med; 1999 Aug; 55(2):50-8. PubMed ID: 10474272
[TBL] [Abstract][Full Text] [Related]
3. Theoretical considerations for the ideal aromatase inhibitor.
Dowsett M
Breast Cancer Res Treat; 1998; 49 Suppl 1():S39-44; discussion S73-7. PubMed ID: 9797016
[TBL] [Abstract][Full Text] [Related]
4. [Aromatase inhibitors].
Feutrie ML; Bonneterre J
Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
[TBL] [Abstract][Full Text] [Related]
5. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Roseman BJ; Buzdar AU; Singletary SE
J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
[TBL] [Abstract][Full Text] [Related]
6. Use of aromatase inhibitors in breast carcinoma.
Santen RJ; Harvey HA
Endocr Relat Cancer; 1999 Mar; 6(1):75-92. PubMed ID: 10732791
[TBL] [Abstract][Full Text] [Related]
7. [Aromatase inhibitors: a review of clinical trials].
Kerbrat P; Lefeuvre C
Bull Cancer; 2000 Dec; 87 Spec No():31-39. PubMed ID: 11250606
[TBL] [Abstract][Full Text] [Related]
8. A roundtable discussion of aromatase inhibitors as therapy for breast cancer.
Allred DC; Baum M; Buzdar AU; Carlson RW; Dowsett M; Elledge RM; Gradishar WJ; Grana G; Howell A; Mamounas EP
Breast J; 2003; 9(3):213-22. PubMed ID: 12752630
[TBL] [Abstract][Full Text] [Related]
9. The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
Hamilton A; Piccart M
Ann Oncol; 1999 Apr; 10(4):377-84. PubMed ID: 10370778
[TBL] [Abstract][Full Text] [Related]
10. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors: past, present and future in breast cancer therapy.
Dutta U; Pant K
Med Oncol; 2008; 25(2):113-24. PubMed ID: 17973095
[TBL] [Abstract][Full Text] [Related]
12. The role of aromatase inhibitors in the treatment of metastatic breast cancer.
Mouridsen H; Gershanovich M
Semin Oncol; 2003 Aug; 30(4 Suppl 14):33-45. PubMed ID: 14513435
[TBL] [Abstract][Full Text] [Related]
13. Current developments in hormonal therapy of breast cancer.
Buzdar AU
Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S4-5. PubMed ID: 15347432
[No Abstract] [Full Text] [Related]
14. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
Pérez N; Borja J
J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical evaluation of aromatase inhibitors antitumor activity].
Auvray P; Bichat F; Genne P
Bull Cancer; 2000 Dec; 87 Spec No():7-22. PubMed ID: 11250604
[TBL] [Abstract][Full Text] [Related]
16. Should aromatase inhibitors replace tamoxifen?
Drug Ther Bull; 2003 Aug; 41(8):57-9. PubMed ID: 12966738
[TBL] [Abstract][Full Text] [Related]
17. Letrozole not superior to anastrozole for early breast cancer.
Brower V
Lancet Oncol; 2017 Mar; 18(3):e138. PubMed ID: 28163005
[No Abstract] [Full Text] [Related]
18. Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Carlini P; Frassoldati A; De Marco S; Casali A; Ruggeri EM; Nardi M; Papaldo P; Fabi A; Paoloni F; Cognetti F
Ann Oncol; 2001 Nov; 12(11):1539-43. PubMed ID: 11822752
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors for breast cancer--further progress.
Rubens RD
Eur J Cancer; 1997 Jun; 33(7):989-90. PubMed ID: 9376202
[No Abstract] [Full Text] [Related]
20. Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy.
Harper-Wynne C; Coombes RC
Eur J Cancer; 1999 May; 35(5):744-6. PubMed ID: 10505035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
